AQR Capital Management - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$363,420
-26.0%
22,079
-10.1%
0.00%0.0%
Q2 2023$490,874
-68.8%
24,556
-70.5%
0.00%
-66.7%
Q1 2023$1,575,241
-70.9%
83,302
-65.1%
0.00%
-75.0%
Q4 2022$5,418,592
+6.0%
238,915
+23.5%
0.01%0.0%
Q3 2022$5,114,000
+44.7%
193,504
+35.3%
0.01%
+50.0%
Q2 2022$3,534,000
+162.9%
143,065
+253.3%
0.01%
+166.7%
Q1 2022$1,344,000
+348.0%
40,491
+360.9%
0.00%
Q1 2021$300,000
+20.0%
8,786
+59.5%
0.00%
Q4 2020$250,000
-38.6%
5,508
-62.8%
0.00%
-100.0%
Q3 2020$407,000
+16.6%
14,794
+56.0%
0.00%0.0%
Q2 2020$349,000
+20.8%
9,481
+6.3%
0.00%
Q1 2020$289,000
-58.7%
8,922
-47.7%
0.00%
-100.0%
Q4 2019$699,000
-50.8%
17,069
-57.3%
0.00%
-50.0%
Q3 2019$1,422,000
-80.3%
39,954
-71.6%
0.00%
-75.0%
Q2 2019$7,229,000
-47.8%
140,725
-41.8%
0.01%
-46.7%
Q1 2019$13,853,000
+13.6%
241,717
-16.8%
0.02%
+7.1%
Q4 2018$12,193,000
-23.8%
290,650
+37.2%
0.01%
-6.7%
Q3 2018$15,993,000
+26.7%
211,830
+20.4%
0.02%
+15.4%
Q2 2018$12,622,000
+604.7%
175,915
+193.2%
0.01%
+550.0%
Q1 2018$1,791,000
+63.1%
60,003
+81.7%
0.00%
+100.0%
Q4 2017$1,098,000
-12.0%
33,030
-12.8%
0.00%0.0%
Q3 2017$1,248,000
+20.9%
37,883
-27.5%
0.00%0.0%
Q2 2017$1,032,00052,2580.00%
Other shareholders
REGENXBIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 847,424$13,948,59912.64%
Sonic GP LLC 518,079$8,527,5808.28%
MPM BioImpact LLC 656,718$10,809,5782.89%
Redmile Group, LLC 2,574,042$42,368,7312.02%
ArchPoint Investors 224,278$3,691,6161.41%
WS MANAGEMENT LLLP 618,131$10,174,4360.82%
Redwood Wealth Management Group, LLC 14,360$236,3660.28%
HARBOR CAPITAL ADVISORS, INC. 48,559$799,2810.17%
PRENTISS SMITH & CO INC 11,240$185,0100.14%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 36,522$601,1520.09%
View complete list of REGENXBIO INC shareholders